Skip to content
Screener

Organon OGN Current ratio

Current ratio at other companies

Pfizer logo
PfizerPFE
1.2×0.0×
Amgen logo
AmgenAMGN
1.4×+0.1×
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
1.3×-0.8×
Biogen logo
BiogenBIIB
1.9×-0.6×
AbbVie logo
AbbVieABBV
0.8×0.0×
Opko Health logo
Opko HealthOPK
3.3×-0.1×

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.56B+57.0%
Enterprise value$11.01B+4.2%
P/E6.6×+2.1×
P/S0.6×+0.2×

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×

Where this comes from

Calculated from Organon’s reported figures.

Based on the most recent quarter.

The source filing: Organon’s 10-Q, filed May 4, 2026. Open the filing →

Filed
May 4, 2026, 8:46 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-029532

FAQ

What is Organon's current ratio?
Organon (OGN) reported current ratio of 2× in Q1 2026.
How has Organon's current ratio changed year-over-year?
Organon's current ratio increased by 18.0% year-over-year, from 1.7× to 2×.
What is the long-term trend for Organon's current ratio?
Over 5 years (2020 to 2025), Organon's current ratio has grown at a 6.4% compound annual growth rate (CAGR), from 1.3× to 1.8×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Ask your AI about Organon's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude